日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Revealing neuroendocrine transformation in gynecological cancers through genomic analysis

通过基因组分析揭示妇科癌症中的神经内分泌转化

Oluloro, Ann; Wells, David L; Childers, Charles K; Luu, Tiffany; Eaton, Keith D; Urban, Renata R; Konnick, Eric Q; Paulson, Vera A; Banda, Kalyan

Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial access

妇科癌症临床试验入组标准作为公平获得临床试验机会的标志

Oluloro, Ann; Swisher, Elizabeth M; Gray, Heidi J; Goff, Barbara; Doll, Kemi M

Impact of Global Enrollment on Race, Ethnicity, and Age Representation in Pivotal Gynecologic Cancer Trials Leading to US Food and Drug Administration Drug Approvals

全球招募对关键妇科癌症试验中种族、民族和年龄代表性的影响,这些试验最终促成美国食品药品监督管理局的药物批准

Khan, Maheen H; Ibanez, Kristen R; Bowen, Courtney; Donohue, Duncan; Oluloro, Ann; Swisher, Elizabeth M; Lee, Jung-Min

Study Protocol for the Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence (SISTER) study: a community engaged national randomized trial

子宫内膜癌及复发治疗期间社会支持干预(SISTER)研究方案:一项社区参与的全国性随机试验

Oluloro, Ann; Comstock, Bryan; Monsell, Sarah E; Gross, Maya; Wolff, Erika M; Sage, Liz; Alson, Julianna; Lavallee, Danielle C; Hempstead, Bridgette; Moore, Adrienne; Katz, Ronit; Doll, Kemi M

What's in it for me?: A value assessment of gynecologic cancer clinical trials for Black women

我能从中得到什么好处?:对黑人女性妇科癌症临床试验的价值评估

Oluloro, Ann; Temkin, Sarah M; Jackson, Jonathan; Swisher, Elizabeth M; Sage, Liz; Doll, Kemi

Endometrial Cancer Knowledge and Guideline-Concordant Practice Patterns Among First-Line Providers

一线医务人员对子宫内膜癌的认知及指南遵循情况

Sage, Liz; Dwyer, Erin; Gray, Dorender A; Oluloro, Ann; Williams, Patrice A; Katz, Ronit; Qualls, Noah J; Doll, Kemi M

Systematic Review of l-Arginine for the Treatment of Hypoactive Sexual Desire Disorder and Related Conditions in Women

左旋精氨酸治疗女性性欲低下症及相关疾病的系统评价

Cieri-Hutcherson, Nicole E; Jaenecke, Andrea; Bahia, Ajeet; Lucas, Debra; Oluloro, Ann; Stimmel, Lora; Hutcherson, Timothy C